The Claim

12/15-lipoxygenase deficiency in mice reduces hepatic steatosis and inflammation to a similar extent as lowering the dietary omega-6 to omega-3 ratio, and both interventions reduce plasma oxidized arachidonic acid metabolites, indicating that 12/15-lipoxygenase is a key enzymatic mediator of omega-6 fatty acid-induced liver damage.

Source: Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
11score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In mice, removing the enzyme 12/15-lipoxygenase reduces fat accumulation and inflammation in the liver, just as reducing dietary omega-6 relative to omega-3 fatty acids does. Both approaches lower levels of oxidized arachidonic acid metabolites in the blood, showing that this enzyme plays a central role in liver damage caused by omega-6 fatty acids.

See the scientific wording

In mice, 12/15-lipoxygenase deficiency reduces hepatic steatosis and inflammation similarly to lowering dietary omega-6 to omega-3 ratio, and both interventions reduce plasma oxidized arachidonic acid metabolites, suggesting that 12/15-lipoxygenase is a key enzymatic mediator of omega-6 fatty acid-induced liver damage.

Why this might work

When omega-6 fats are abundant, the enzyme 12/15-lipoxygenase converts arachidonic acid into inflammatory molecules that activate liver immune cells, trigger the release of signaling proteins that attract immune cells, and increase fat production in liver cells, leading to fat buildup and tissue damage. Removing this enzyme or reducing omega-6 fats stops this chain, preventing liver damage.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Reduced Dietary Omega-6 to Omega-3 Fatty Acid Ratio and 12/15-Lipoxygenase Deficiency Are Protective against Chronic High Fat Diet-Induced Steatohepatitis

    In mice, removing the 12/15-lipoxygenase enzyme or eating less omega-6 and more omega-3 fats both helped reduce liver fat and inflammation, and lowered the same harmful fat byproducts — showing the enzyme is a major way these fats hurt the liver.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.